Northwestern Mutual Investment Management Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.3M Sell
25,356
-18
-0.1% -$18.2K 0.35% 24
2025
Q4
$27.3M Buy
25,374
+36
+0.1% +$34.4K 0.32% 23
2025
Q3
$19.3M Buy
25,338
+244
+1% +$182K 0.28% 21
2025
Q2
$19.6M Buy
25,094
+33
+0.1% +$25.6K 0.3% 21
2025
Q1
$20.7M Buy
25,061
+43
+0.2% +$35.8K 0.33% 21
2024
Q4
$19.3M Buy
25,018
+16
+0.1% +$13.2K 0.43% 20
2024
Q3
$22.2M Sell
25,002
-404
-2% -$363K 0.52% 18
2024
Q2
$23M Buy
25,406
+103
+0.4% +$82.4K 0.6% 17
2024
Q1
$19.7M Buy
25,303
+63
+0.2% +$44.8K 0.51% 16
2023
Q4
$14.7M Buy
25,240
+71
+0.3% +$41.4K 0.38% 22
2023
Q3
$13.5M Buy
25,169
+316
+1% +$163K 0.37% 20
2023
Q2
$11.7M Buy
24,853
+62
+0.3% +$26K 0.3% 24
2023
Q1
$8.51M Buy
24,791
+72
+0.3% +$24.3K 0.22% 28
2022
Q4
$9.04M Sell
24,719
-4,572
-16% -$1.62M 0.23% 26
2022
Q3
$9.47M Sell
29,291
-6,406
-18% -$2.03M 0.24% 26
2022
Q2
$11.6M Buy
35,697
+4,114
+13% +$1.23M 0.26% 27
2022
Q1
$9.04M Sell
31,583
-7,742
-20% -$1.99M 0.2% 49
2021
Q4
$10.9M Sell
39,325
-475
-1% -$120K 0.21% 46
2021
Q3
$9.2M Buy
39,800
+3,653
+10% +$902K 0.18% 52
2021
Q2
$8.3M Buy
36,147
+84
+0.2% +$16.9K 0.14% 60
2021
Q1
$6.74M Sell
36,063
-7,509
-17% -$1.47M 0.12% 65
2020
Q4
$7.36M Sell
43,572
-2,694
-6% -$402K 0.1% 71
2020
Q3
$7.6M Hold
46,266
0.1% 60
2020
Q2
$7.6M Buy
46,266
+2,247
+5% +$345K 0.11% 58
2020
Q1
$6.11M Buy
44,019
+11,198
+34% +$1.54M 0.09% 77
2019
Q4
$4.31M Buy
32,821
+468
+1% +$54.2K 0.08% 93
2019
Q3
$3.62M Sell
32,353
-421
-1% -$46.9K 0.08% 96
2019
Q2
$3.63M Sell
32,774
-98,452
-75% -$11.6M 0.09% 97
2019
Q1
$17M Sell
131,226
-11,368
-8% -$1.38M 0.31% 72
2018
Q4
$16.5M Sell
142,594
-24,671
-15% -$2.76M 0.28% 67
2018
Q3
$17.9M Sell
167,265
-15,647
-9% -$1.56M 0.27% 81
2018
Q2
$15.6M Buy
182,912
+7,419
+4% +$609K 0.23% 78
2018
Q1
$13.6M Sell
175,493
-43,352
-20% -$3.49M 0.23% 83
2017
Q4
$18.5M Buy
218,845
+1,625
+0.7% +$138K 0.31% 71
2017
Q3
$18.6M Sell
217,220
-5,595
-3% -$459K 0.31% 64
2017
Q2
$18.3M Buy
222,815
+26,544
+14% +$2.17M 0.31% 65
2017
Q1
$16.5M Buy
196,271
+84,718
+76% +$6.79M 0.29% 63
2016
Q4
$8.21M Buy
111,553
+15,453
+16% +$1.15M 0.16% 71
2016
Q3
$7.71M Buy
96,100
+59,041
+159% +$4.73M 0.16% 65
2016
Q2
$2.92M Sell
37,059
-107
-0.3% -$8.06K 0.06% 138
2016
Q1
$2.68M Buy
37,166
+89
+0.2% +$6.73K 0.06% 153
2015
Q4
$3.12M Buy
37,077
+932
+3% +$77.3K 0.07% 165
2015
Q3
$3.02M Sell
36,145
-15
-0% -$1.27K 0.06% 168
2015
Q2
$3.02M Buy
36,160
+505
+1% +$38.5K 0.06% 184
2015
Q1
$2.59M Buy
+35,655
New +$2.54M 0.05% 216

Other funds holding LLY

Northwestern Mutual Investment Management Company's LLY Position: Q1 2026 in Review

Northwestern Mutual Investment Management Company reduced its Eli Lilly (LLY) stake by 0.07% in Q1 2026, selling an estimated $18.2K and leaving 25,356 shares worth $23.3M. The position accounts for 0.35% of the portfolio, ranked #24.

Northwestern Mutual Investment Management Company first reported a position in LLY in Q1 2015 and has held it in 45 quarters since. The position peaked at $27.3M in Q4 2025. 4,366 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Northwestern Mutual Investment Management Company held 25,356 shares of Eli Lilly worth $23.3M as of Q1 2026.
  • Northwestern Mutual Investment Management Company sold 18 Eli Lilly shares in Q1 2026, an estimated $18.2K.
  • Eli Lilly made up 0.35% of Northwestern Mutual Investment Management Company's portfolio in Q1 2026, its #24 holding.
  • Northwestern Mutual Investment Management Company first reported a position in Eli Lilly in Q1 2015 and has held it in 45 quarters since.
  • Northwestern Mutual Investment Management Company's Eli Lilly position peaked at $27.3M in Q4 2025.
  • 4,366 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q1 2026, filed 8 May 2026.